1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
View analysts' price targets and recommendations, and compare them with competitors.
No Data
No price target data available for this metric.
Hold
Positive consensus among analysts.
Analyze analyst forecasts for the company and compare them with competitors.
251.32M
The estimated revenue has increased from the previous period.
20.82M
The estimated EBITDA has increased from the previous period.
-2.93
The estimated EPS has decreased from the previous period.
-2.18B
The estimated net income has decreased from the previous period.
-21.29M
The estimated EBIT has decreased from the previous period.
83.22M
The estimated SG&A expenses have increased from the previous period.
Analyze DCF forecasts for the company and compare them with competitors.
1.36B
Revenue has increased from the previous period.
19.82%
Revenue growth rate has decreased from the previous period.
-533.65M
EBITDA has decreased from the previous period.
-39.14%
EBITDA margin has decreased from the previous period.
-657.15M
EBIT has decreased from the previous period.
-48.20%
EBIT margin has decreased from the previous period.
180.09M
Depreciation has decreased from the previous period.
975.12M
Total cash has increased from the previous period.
71.52%
Cash percentage has increased from the previous period.
201.46M
Receivables have increased from the previous period.
14.78%
Receivables percentage has increased from the previous period.
550.04M
Inventories have increased from the previous period.
40.34%
Inventory percentage has increased from the previous period.
156.36M
Accounts payable has increased from the previous period.
11.47%
Payables percentage has decreased from the previous period.
-121.17M
Capital expenditure has increased from the previous period.
-8.89%
CapEx percentage has increased from the previous period.
14.21%
WACC has increased from the previous period.
14.92%
Cost of equity is unchanged from the previous period.
12.72%
Cost of debt is unchanged from the previous period.
2.19
Beta is unchanged from the previous period.
742.65M
Diluted shares outstanding is unchanged from the previous period.
558.58M
Total debt is unchanged from the previous period.
1.30B
Total equity is unchanged from the previous period.
1.86B
Total capital is unchanged from the previous period.
30.06%
Debt weighting is unchanged from the previous period.
69.94%
Equity weighting is unchanged from the previous period.
-649.00M
EBIAT has decreased from the previous period.
-827.00M
UFCF has decreased from the previous period.
2.00%
Long-term growth rate is unchanged from the previous period.
-11.86B
Terminal value is unchanged from the previous period.
-9.55B
Enterprise value has increased from the previous period.
229.28M
Net debt is unchanged from the previous period.
-9.78B
Equity value has increased from the previous period.
-13.17
Equity value per share is unchanged from the previous period.
